CareFusion's (CFN) ChloraPrep Study Shown to Reduce SSIs by 41% Versus Povidone-Iodine Solution
Tweet Send to a Friend
Data published today in The New England Journal of Medicine demonstrates that use of CareFusion's (NYSE: CFN) patient preoperative skin ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
